Last reviewed · How we verify
NCT06347523
VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction
NA trial testing The VR-based preoperative rehabilitation program; in Anterior Cruciate Ligament (ACL) Reconstruction in 100 participants. Terminated before completion.
1 March 2025
Quick facts
| Lead sponsor | First Affiliated Hospital of Shantou University Medical College |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 2 April 2024 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- The VR-based preoperative rehabilitation program;
- standard nursing care,
Conditions studied
- Anterior Cruciate Ligament (ACL) Reconstruction — all drugs for Anterior Cruciate Ligament (ACL) Reconstruction →
- Preoperative Rehabilitation — all drugs for Preoperative Rehabilitation →
Sponsor
First Affiliated Hospital of Shantou University Medical College
Who can join
Adults 18 to 60, any sex, with Anterior Cruciate Ligament (ACL) Reconstruction or Preoperative Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Between April 2, 2024, and October 1, 2024, a study will be conducted at the Department of Orthopedics in the First Affiliated Hospital of Shantou University Medical College involving 120 patients who will undergo anterior cruciate ligament reconstruction surgery. They will be randomly divided into two groups: an experimental group and a control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06347523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anterior Cruciate Ligament (ACL) Reconstruction
Currently open trials in the same condition.
- NCT06974526 — Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgica · Phase 2 · recruiting
Other First Affiliated Hospital of Shantou University Medical College trials
Trials by the same sponsor.
- NCT05686720 — Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer · EARLY_PHASE1 · unknown
- NCT03156673 — Treatment of COPD by Autologous Transplantation of Bronchial Basal Cells · EARLY_PHASE1 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06347523 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Shantou University Medical College
- Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06347523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing